ARDS Earnings
Aridis Pharmaceuticals, Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: -50.0%
1Y: -92.3%
3Y: -99.9%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Next Earnings
2026-11-02
EPS Estimate
$-0.63
Range: $-0.63 - $-0.63
Revenue Estimate
$450K
1 analysts
Estimate vs Actual
Earnings Surprise History
Wall Street Forward Estimates
Quarterly
Annual
Estimate Revisions
Recent Revisions
| Date | Period | Fiscal Date | EPS Old | EPS New | Change | Rev Old | Rev New |
|---|---|---|---|---|---|---|---|
| 2026-10-01 | quarter | 2027-12-30 | $-0.17 | $-0.06 | ▲ 0.11 | $11,200,000 | $10,462,500 |
| 2026-10-01 | quarter | 2029-06-30 | $-0.10 | $-0.02 | ▲ 0.08 | $1,500,000 | $300,000 |
| 2026-10-01 | quarter | 2026-09-30 | $-0.63 | $-0.60 | ▲ 0.03 | $450,000 | $266,667 |
| 2026-10-01 | quarter | 2027-09-30 | $-0.06 | $-0.51 | ▼ 0.45 | $10,462,500 | $2,000,000 |
| 2026-10-01 | quarter | 2029-03-30 | $-0.02 | $-0.10 | ▼ 0.08 | $300,000 | $1,500,000 |
| 2026-10-01 | quarter | 2026-12-30 | $-0.51 | $-0.63 | ▼ 0.12 | $500,000 | $450,000 |
| 2026-10-01 | quarter | 2028-06-30 | $-0.10 | $-0.41 | ▼ 0.31 | $1,500,000 | $462,500 |
| 2026-10-01 | quarter | 2027-03-30 | $-0.41 | $-0.51 | ▼ 0.10 | $5,700,000 | $500,000 |
| 2026-10-01 | quarter | 2027-06-30 | $-0.51 | $-0.41 | ▲ 0.10 | $2,000,000 | $5,700,000 |
| 2026-10-01 | quarter | 2028-03-30 | $-0.41 | $-0.17 | ▲ 0.24 | $462,500 | $11,200,000 |
| 2026-08-11 | annual | 2019-12-31 | $— | $-3.58 | ▼ 3.58 | $— | $1,261,000 |
| 2026-08-11 | annual | 2018-12-31 | $— | $-32.48 | ▼ 32.48 | $— | $1,724,500 |
| 2026-08-11 | annual | 2020-12-31 | $— | $-2.44 | ▼ 2.44 | $— | $1,500,000 |
| 2026-08-11 | annual | 2022-12-31 | $— | $-1.74 | ▼ 1.74 | $— | $2,193,667 |
| 2026-08-11 | annual | 2021-12-31 | $— | $-3.57 | ▼ 3.57 | $— | $2,432,000 |
Earnings Call Transcripts
No transcripts available.